Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Clinical trial NCT06650501 · RECRUITING

Trial details

NCT number: NCT06650501
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Staphylococcus Aureus Endocarditis Staphylococcus Aureus Septicemia Staphylococcus Aureus Bacteremia Staphylococcus Aureus Bloodstream Infection S. Aureus Bacteremia S. Aureus Bloodstream Infection

Start date: 2026-01-15
Primary completion: 2030-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.